Lv32
256 积分 2024-10-22 加入
Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography–mass spectrometry
3天前
已完结
Metabolomics of lung cancer: Analytical platforms and their applications
3天前
已完结
Non–Risk-Based Lung Cancer Screening With Low-Dose Computed Tomography
28天前
已完结
Occupational asbestos exposure and survival among lung cancer patients
1个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
1个月前
已完结
Passive Smoking–Induced Mutagenesis as a Promoter of Lung Carcinogenesis
1个月前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
2个月前
已完结
Exosomal PD-L1 in non-small cell lung Cancer: Implications for immune evasion and resistance to immunotherapy
2个月前
已完结
Novel therapeutic approaches for non-small cell lung cancer: an updated view
2个月前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
2个月前
已完结
皖公网安备34019202002308
